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Abstract
Background: Secondary therapy-related acute lymphoblastic leukemia might emerge following chemotherapy
and/or radiotherapy for primary malignancies. Therefore, other alternatives should be pursued to treat leukemia.
Results: It is shown that vitamin K3- or vitamin C- induced apoptosis in leukemia cells by oxidative stress
mechanism involving superoxide anion radical and hydrogen peroxide generation, activation of NF-B, p53, c-Jun,
protease caspase-3 activation and mitochondria depolarization leading to nuclei fragmentation. Cell death was
more prominent when Jurkat and K562 cells are exposed to VC and VK3 in a ratio 1000:1 (10 mM: 10 μM) or 100:1
(300 μM: 3 μM), respectively.
Conclusion: We provide for the first time in vitro evidence supporting a causative role for oxidative stress in VK3-
and VC-induced apoptosis in Jurkat and K562 cells in a domino-like mechanism. Altogether these data suggest that
VK3 and VC should be useful in the treatment of leukemia.
Background
Leukemia is a cancer of the bone marrow and blood. The
cause of this hematological disorder is currently still
unknown. Today, first-line therapy for the treatment of
leukemia includes chemotherapy and radiotherapy.
Unfortunately, secondary therapy-related acute lympho-
blastic leukemia might emerge following chemotherapy
and/or radiotherapy for primary malignancies [1]. There-
fore, other therapeutic alternatives based on the reactiva-
tion of the apoptotic program should be pursued to
eliminate cancer cells [2]. Accordingly, the use of vitamin
K3 (VK3, also known as menadione [3]) and vitamin C
(VC, also known as sodium ascorbate [4]) alone or in
combination (VK3: VC [5]) is highly promising in cancer
treatment. Yet, the precise pathway(s) by which VK3
and/or VC induce leukemia cell death are not well estab-
lished. Moreover, given the complexity of death pathways
within a cell, placing these pathways in the proper rela-
tionship to the drug trigger is challenging.
During the last three decades, vitamin K3 has been
known to display anti-tumor action both in vivo and in
vitro in human cancer cell lines [4]. Several observations
suggest that vitamin K3 might induce apoptosis -a type
of cell death- [6] through different biochemical routes
including severe depletion of glutathione and sulfhydryl-
containing proteins and alteration of intracellular Ca
2+
homeostasis [7], activation of c-Jun NH2-terminal kinase
(JNK, [8]), activation of Fas/Fas ligand system indepen-
dently of the pro-apoptotic p53 protein [9], activation of
Fas-dependent and Fas-independent pathways [10] and
NF-B activation [11]. Because most studies have looked
at a given pathway in isolation using different cell types,
the potential interaction between pathways have often
not been addressed. Therefore, the complete mechanism
(s) of cell death signalization induced by vitamin K3 in a
single cell model remains unclear.
Vitamin C is a water-soluble vitamin effective as antioxi-
dant compound under normal conditions [12]. However,
Chen and collaborators [13,14] have shown that pharma-
cological concentrations of (5-15 mM) vitamin C was pro-
oxidant, generating H2O2-dependent cytotoxicity toward a
variety of cancer cells in vitro and in vivo without
adversely affecting normal cells. Interestingly, it has been
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kill leukemia cells (e.g., K562 cells) by oxidative stress
independent of caspase-3, with a minor percentage of cell
displaying mitochondrial depolarisation and DNA frag-
mentation without chromatin condensation consistent
with a necrosis-like cell death [15]. Yet, the mechanism by
which vitamin C-induced apoptosis in Jurkat and K562
cells is not yet fully established.
Since it is known that the transcription factor NF-B
[16], p53 [17], c-Jun [18] and caspase-3 [19] are involved
in apoptosis signaling, we hypothesized that VK3 and
VC might induce cell death in leukemia cells through
activation of such factors by oxidative stress. To test
this assumption, we sought to investigate the molecular
mechanism by which VC, VK3 alone or in combination
(ratio 100:1 [20]) induce cell death in Jurkat (clone E06-
1) and K562 leukemia cell lines and lymphocyte cells in
relation to the aforementioned pro-apoptotic transcrip-
tion factors and caspase-3. Although, the role of vitamin
C as therapeutic compound is still controversial [21],
understanding the mechanism of vitamins alone or
together may provide insight into more effective anti-
cancer therapy.
Results
Vitamin K3 (VK3) and vitamin C (VC) alone or in
combination induce apoptosis in Jurkat and K562 cells
through anion superoxide radical (O2
.-)/H2O2 generation
and mitochondrial damage
F i g u r e1 Aa n d1 Bs h o wt h a tV K 3a n dV Cp r o v o k e d
typical morphological features of apoptosis in a concen-
tration-dependent fashion according to the conventional
AO/EB staining technique [22]. However, (early/late)
apoptosis and necrosis (~20%-50%) morphology of cell
death were observed at high VK3 (e.g., 35 μMf o rb o t h
cells) and VC (e.g., 20 mM for Jurkat and > 1 mM for
K562) concentrations (insets). Remarkably, K562 cells
were the most sensible to VC, whereas both cell lines
were more sensible to VK3 than lymphocytes (e.g. Jurkat
and K562 cells displayed ~40% & ~25% AO/EB positive
nuclei whereas lymphocytes displayed about 3% AO/EB
positive nuclei when exposed to 10 μM VK3). These
results prompted us to fully examine the effect of VK3
and VC on Jurkat cell line.
Figure 1C shows that VK3 produced both anion superox-
ide radical (O2
.-) and H2O2 in a concentration-dependent
fashion up-to 20 μM, e.g. 94% and 43% percent of forma-
zan (Figure 2A) and DCF positive (Figure 2B), respectively
in Jurkat cells. Figure 1C also shows that increasing con-
centrations of VK3 induced mitochondrial depolarization,
as reflected by DiOC6(3) non-fluorescent cells (Figure 2C)
in a concentration-dependent fashion. Interestingly, apop-
totic morphological alterations (Figure 2D) were associated
with mitochondrial depolarization. Since high VK3
concentrations (e.g. > 35 μM) induced nuclear and cyto-
plasmic destruction of cells (necrosis), thus avoiding a
clear-cut evaluation of apoptotic morphology (data not
shown), 10 μM VK3 was selected for further experiments.
Recently, it has been shown that mM concentrations
of ascorbate were cytotoxic to neuroblastoma cells
mediated by H2O2 [ 2 3 ] .F i g u r e1 Ds h o w st h a tV Cw a s
capable to generate either O2
.- or H2O2 at the indicated
concentrations. Moreover, VC was moderately or highly
toxic to Jurkat and K562 cells, respectively at high con-
centrations. Of note, whilst 1 mM VC induced apopto-
tic/necrotic morphology in K562, 10 mM concentration
induces apoptosis in Jurkat to a similar extend provoked
by (10 μM) VK3. Interestingly, VC was innocuous for
lymphocyte cells at the indicated concentrations.
A ratio 1000: 1 and 100: 1 VC: VK3 provoke apoptosis in
Jurkat cells and K562 cells, respectively
Table 1 shows that a ratio 100:1 (VC: VK3) did not
affect Jurkat cells, but this ratio (300 VC: 3VK3) induced
(~30%) apoptosis in K562, according to AO/EB and
DiOC6(3) staining techniques. A ratio 1000:1 resulted in
an effective toxic effect in Jurkat cell line.
VK3 and VC alone or in combination induce apoptosis
through of reactive oxygen species
CP55,940 [24] and N-acetyl-cysteine (NAC) antioxidants
dramatically reduced apoptosis to almost control values
and importantly abrogated H2O2 when cells where trea-
ted with VK3, VC alone or VK3 in combination with VC
(Table 2). A similar protective effect was observed when
K562 cells were exposed to (20 μM) VK3, (0.5 mM) VC
and VC: VK3 in a ratio 300:3 and antioxidants (data not
shown).
VK3 and VC alone or in combination induce apoptosis in
Jurkat and K562 cells associated with NF-B, p53 and c-
Jun transcription factors and caspase-3 activation
Table 3 shows that all the specific pharmacological inhi-
bitors reduced almost completely VK3- and VC-induced
apoptosis and mitochondrial damage effect compared to
control values, but moderately reduced cell death and
Δψm when cells were exposed in combination (~30-44%
reduction). To confirm the participation of NF-B, p53,
c-Jun and caspase-3 in VK3, VC and VK3 plus VC-
induced apoptosis, we performed immunocytochemical
assessment. As illustrated in Figure 3 B, D, F, and H,
Jurkat cells incubated with 10 μMV K 3c l e a r l ys h o w e d
DAB
+ nuclei staining of the active form of NF-B
(~36%), p53 (~38%), c-Jun (~40%) and CASP-3 (~40%)
compared to untreated cells (1-2% DAB
+ nuclei), where
inactive transcription factors and protease reside in the
cytoplasm (Figure 3 A, C, E and G). In addition, immu-
nocytochemical assessment of cells treated with VC
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+ nuclei staining of NF-B( ~ 1 8 % ) ,
p53 (~15%), c-Jun (~15%) and CASP-3 (~16%) (Figure 4
A, C, E and G, respectively) compared to untreated
cells. Not surprisingly, treated cells with (10 μM) VK3
in combination with (10 mM) VC stained DAB
+ for NF-
B (~38%, Figure 4B), p53 (~75%, Figure 4D), c-Jun
(~48%, Figure 4F) and caspase-3 (~47%, Figure 4H)
compared to untreated cells. Likewise, K562 cells treated
with (500 μM) VC, (20 μM) VK3 and (300:3) VC/VK3
showed DAB
+ nuclei staining for NF-B, p53, c-Jun and
CASP-3 to a similar extend as Jurkat cells (data not
shown).
Discussion
I nt h ep r e s e n ts t u d y ,w ep r o v i d ef o rt h ef i r s tt i m ein
vitro evidence supporting a causative role for oxidative
stress in VK3-, and VC-induced apoptosis in Jurkat and
K562 cells in a domino-like mechanism involving O2
.-/
H2O2, mitochondrial depolarization, transcription factor
activation such as NF-, p53, and c-Jun converging in
caspase-3 activation and apoptotic morphology. Most
importantly, it is shown that high concentration of VC
(e.g. 10 mM) alone or in combination with VK3 (e.g. 10
μM) in a ratio 1000:1 and 100:1 induced apoptosis in
Jurkat and K562 cells, respectively by a comparable
mechanism to VK3 (e.g. 10 μM) and VC (e.g. 10 mM)
alone. Moreover, by using antioxidant compounds, we
demonstrated that O2
.-/H2O2 production are essential in
VK3-and VC-induced cytotoxicity. This notion was
further reinforced by the fact that the antioxidant
CP55,940 and NAC completely protect leukemia cells
against VK3- and VC-superoxide radicals and H2O2
Figure 1 Vitamin K3 (VK3) and vitamin C (VC) produce reactive oxygen species, mitochondrial depolarization and nuclear morphology
indicative of apoptosis in lymphocyte and leukemia cells. Lymphocyte, Jurkat and K562 were incubated with increasing concentration of
VK3 (A) and VC (B) for 24 h. Nuclear morphological changes was evaluated using AO/EB staining. Inset: Representative fluorescent
photomicrography shows cell shrinkage and rounding, chromatin condensation (arrows), nuclei fragmentation (arrowheads) indicative of
apoptosis and necrotic cells (asterisk) in K562 cells treated with (35 μM) VK3 (A) and (1 mM) VC (B). The ANOVA showed significantly differences
among the three cells groups, p < 0.0001; post-hoc comparison showed significantly increase in cell death morphology in the leukemia cells on
each VK3 and VC concentration versus lymphocytes. Jurkat cells were incubated with (10 μM) VK3 (C) and (10 mM) VC (D) for 24 h. Cells were
evaluated for O2
.-/H2O2 production, Δψm and nuclear morphological changes indicative of apoptosis. NBT
+ stained blue-purple precipitate cells,
DCF
+ green fluorescent cells, DiOC6(3)
high/low+ green fluorescent cells and apoptotic nuclei percentage is expressed as mean of percentage (%) ±
S.D. from three independent experiments. ANOVA test for each condition showed differences among groups p < 0.0001. The post-hoc
comparison showed increase in number of DCF, AO/EB and NBT
+ cells, whereas the number of DiOC6(3)
+ cells decreased in a concentration-
dependent fashion. One-way ANOVA analysis with Bonferroni post-hoc analysis was performed. A p-value of
ap < 0.05 and
bp < 0.001 Jurkat
versus K562 or
cp < 0.05 and
dp < 0.001 versus lymphocytes (A, B) or control (C, D) was considered significant.
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resistant to cell death induced either by VC or VK3
treatment alone than leukemia cells. We speculate that
differences in cell cycle (i.e., lymphocytes are in Go cell
cycle and cancer cells are constantly dividing cells), dif-
ferences in glutathione content and/or differences in
gene expression of antioxidant proteins (e.g., catalase,
thioredoxin, superoxide dismutase, glutathione peroxi-
dase) may explain resistance and/or vulnerability in lym-
phocyte and leukemia cells against VK3 and VC
exposure. Taken together our results suggest that differ-
ent compounds with varied chemical properties might
present a similar oxidative stress mechanism of action
to erode leukemia cells.
We confirm that VK3 [25] and VC at high concentra-
tions [13,14,26] generate O2
.- and H2O2. Moreover, by
using antioxidant compounds, it is shown that both
reactive oxygen species are related to apoptotic mor-
phology. Our result comply with the notion that H2O2,
as a by-product of O2
.- dismutation, provokes apoptosis
in Jurkat and K562 cells [26]. How H2O2 might be
involved in cell death process? Takada and co-workers
[27] have demonstrated that H2O2 induces NF-Ba c t i -
vation in Jurkat cells through the spleen tyrosine kinase
(Syk). Alternatively, H2O2 m a ya c t i v a t eN F - Bt h r o u g h
phosphorylation IBa kinase (IKKa)a n dI K K b [28]). In
accordance with these observations, we found p65-DAB
+ nuclei by immunohistochemistry technique in both
Figure 2 Vitamin K3 (VK3) generates anion superoxide radicals (O2
.-), hydrogen peroxide (H2O2), mitochondrial depolarization and
apoptotic morphology in Jurkat cells. Jurkat cells (1 × 10
6 cells/mL) were incubated with (10 μM) VK3 at different interval as
indicated below. (A) Representative light photomicrography showing NBT
+ stained blue-purple precipitate cells (i.e. formazan, arrows) and NBT
-
stained cells (i.e. translucent cells, arrowheads) indicative of positive and negative (O2
.-) production, respectively from Jurkat cells incubated with
VK3 for 3 h at 37 °C. Insets: Magnification of four NBT
+ cells showing cytoplasmic blue-purple precipitate from Jurkat cells incubated with VK3 for
24 h at 37 °C. (B) Representative fluorescent photomicrography (ex. 450-490 nm, em. 515 nm) illustrating DCF
+ (green bright light, arrowheads)
and DCF
- (dark round-shape, asterisks) fluorescent stained cells indicative of positive and negative H2O2 production, respectively. (C)
Representative fluorescent photomicrography (ex. 450-490 nm, em. 515 nm) illustrating DiOC6(3)
+ green fluorescent (arrowheads) stained cells
indicative of high-polarized and low-polarized mitochondria and DiOC6(3)
- (non-fluorescent, asterisks) stained cells indicative of depolarized
mitochondria. (D) Representative fluorescent photomicrography (ex. 450-490 nm, em. 515 nm) showing typical nuclear apoptotic morphology
such as highly condensed chromatin (asterisks) and nuclear fragmentation (arrowheads) from Jurkat cells treated with (10 μM) VK3. Magnification
A: 1000x (inset 1200x); B: 600x; C: 800x; D: 1000x.
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tion of p65 activation and translocation to the nuclei,
but almost undetectable in untreated cells. Moreover,
pharmacological inhibition of NF-B with PDTC inhib-
ited to almost control value the apoptotic morphology.
Taken together these data suggest that VK3 and VC
induce activation and translocation of the NF-B( p 6 5 )
probably via H2O2-induced mechanisms. Our results are
in agreement with Jones et al. [12]. However, our results
differ from Han et al. [29] who showed VC toxicity in
HL-60 cells through down-regulation of NF-Ba c t i v i t y .
Although the nature of this discrepancy is not known,
one possible explanation is that HL-60 cells constitu-
tively express NF-B (also called “NF-B positive” can-
cer cells), which confers cell survival [30]. We conclude
that depending on the inducible or constitutive expres-
sion NF-B profile in cells, NF-B will be an important
factor to determine the appropriate therapeutic strategy
against lymphoblastic/myelogenous leukemia. Conse-
quently, NF-B may constitute an important therapeutic
target [31]. In accordance with other scientific reports
and our present data suggest that activation of NF-Bi s
linked to cell death signaling in Jurkat and K562 cells
[16]. Indeed, NF-B transcribes pro-apoptotic genes
such as p53. Immunohistochemical detection of p53
may indicate that p53 can be directly up-regulated by
NF-B. Moreover, pharmacological inhibition of p53 by
PFT completely abolishes VK3 and VC-evoked apopto-
sis. In contrast to Karczewski et al. [32], our data com-
ply with the notion that p53 is involved in the
mechanism of VK3 and VC toxicity in Jurkat and K562
cells [33]. It is noteworthy to mention that p53 tran-
scribes pro-apoptotic genes such as PUMA, Noxa, Bim,
Bid, Bax, which are able to permeabilize mitochondria,
thus promoting the release of the apoptogenic cyto-
chrome c, which elicits caspase-3 protease activation,
leading to nuclear chromatin fragmentation, typical of
apoptotic morphology. In fact, caspase-3 NSCI inhibitor
protected cells from those noxious stimuli. In contrast
to Verrax et al. [15], our data clearly showed that VC,
VK3 or VC/VK3 induced toxicity in Jurkat and K562
cells by caspase-3 dependent form of cell death.
Table 1 Effect of different ratio combination of Vitamin





Untreated < 1 ± 0 > 99 ± 0
VK3 (1 μM) 1 ± 1 98 ± 1
VC (100 μM) 1 ± 0 99 ± 1
VK3 (1 μM) + VC (100 μM) 1 ± 1 98 ± 1
VK3 (2 μM) 1 ± 1 98 ± 1
VC (200 μM) 1 ± 1 98 ± 2
VK3 (2 μM) + VC (200 μM) 2 ± 1 97 ± 1
VK3 (3 μM) 5 ± 1
a 96 ± 1
VC (300 μM) 4 ± 1
a 97 ± 1
VK3 (3 μM) + VC (300 μM) 2 ± 1
a 97 ± 2
VK3 (4 μM) 11 ± 1
a 87 ± 3
a
VC (400 μM ) <1±0
c >9 9±0
c
VK3 (4 μM) + VC (400 μM) 8 ± 1
a,b 92 ± 2
a,b,c
VK3 (5 μM) 22 ± 1
a 73 ± 2
a
VC (500 μM) 2 ± 1
c 97 ± 1
c
VK3 (5 μM) + VC (500 μM) 10 ± 2
a,b,c 88 ± 2
a,c
VC (5000 μM) 3 ± 1 97 ± 2
b,c
VK3 (5 μM) + VC (5000 μM) 48 ± 2
a,b,c 68 ± 2
a,b,c
VK3 (10 μM) 35 ± 3
a 60 ± 2
a
VC (10000 μM) 26 ± 2
a 75 ± 3
a,c
VK3 (10 μM) + VC (10000 μM) 58 ± 3
a,b,c 63 ± 3
a,b
Jurkat cells (1 × 10
6 cell/mL) were left untreated or treated with VC or VK3
alone or in combination at the indicated concentration for 24 h. After this
time, mitochondrial membrane potential and nuclear morphological changes
were evaluated using DiOC6(3) and acridine orange/ethidium bromide (AO/EB)
staining, as described in Materials and Methods. High polarized and low-
polarized mitochondria (green fluorescent DiOC6(3) high/low positive cells)
and positive apoptotic nuclei percentage is expressed as mean of percentage
(%) ± S.D. from three independent experiments. A one-way ANOVA analysis
was performed, p < 0.0001.
aSignificantly different from untreated by
Bonferroni post-hoc analysis for DiOC6(3) and Games-Howell post hoc
comparison for AO/EB.
bSignificantly different from VC by Bonferroni post-hoc
analysis for DiOC6(3) and Games-Howell post hoc comparison for AO/EB.
cSignificantly different from VK3 by Bonferroni post-hoc analysis for DiOC6(3)
and Games-Howell post hoc comparison for AO/EB.
Table 2 Hydrogen peroxide (H2O2) is involved in vitamin






Untreated < 1 ± 0 2 ± 1
VC (10 mM) 26 ± 2 28 ± 2
VK3 (10 μM) 35 ± 3 39 ± 3
VK3 (10 μM) + VC (10 mM) 48 ± 3 55 ± 3
CP55,940 (10 nM) < 1 ± 0 1 ± 1
CP55,940 (10 nM) + VC (10 mM) 1 ± 1
b 1±1
b
CP55,940 (10 nM) + VK3 (10 μM) 2 ± 1
a 8±2
a
CP55,940 (10 nM) + VC (10 mM) + VK3 (10 μM) 3 ± 1
c 14 ± 2
c
NAC (1 mM) < 1 ± 0 1 ± 0
NAC (1 mM) + VC (10 mM) 2 ± 1
b 7±2
b
NAC (1 mM) + VK3 (10 μM) 4 ± 1
a 12 ± 2
a
NAC (1 mM) + VC (10 mM) + VK3 (10 μM) 7 ± 1
c 20 ± 2
c
Jurkat cells (1 × 10
6 cell/mL) were left untreated or treated with VC (10 mM)
or VK3 (10 μM) alone or with VC (10 mM): VK3 (10 μM) in the absence or
presence of the antioxidant CP55,940 (10 nM) and N-acetyl-cysteine (NAC, 1
mM) at 37 °C for 24 h. After this time, nuclear morphological changes and
hydrogen peroxide (H2O2) generation were evaluated using acridine orange/
ethidium bromide (AO/EB) and 2’,7’-dichlorofluorescein diacetate (DCFH2-DA)
staining, as described in Material and Methods. Positive apoptotic nuclei and
green fluorescent dichlorofluorescein (DCF) positive cells percentage is
expressed as mean of percentage (%) ± S.D. from three independent
experiments. A one-way ANOVA analysis was performed, p < 0.0001.
aSignificantly different from VK3 by Bonferroni post-hoc analysis for DCF and
Games-Howell post hoc comparison for AO/EB.
bSignificantly different from VC
by Bonferroni post-hoc analysis for DCF and Games-Howell post hoc
comparison for AO/EB.
cSignificantly different from VK3-VC by Bonferroni post-
hoc analysis for DCF and Games-Howell post hoc comparison for AO/EB.
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macological blockade, we found that VK3 and VC acti-
vate c-Jun. How, then, these concurrent signaling
pathways are activated either by VK3, VC or H2O2?A s
mentioned above, H2O2 can directly activate NF-B
through Syk or indirectly by activation of the multisubu-
nit IKKa/b by Syk or MEKK1/MAPKK kinase. Therefore,
one possibility is that once MEKK1 is activated, it may
serve as a cross talk molecule between the JNK and NF-
B pathway [34]. Taken together our findings and this
information, it is reasonable to assume that NF-Ba n d
JNK/c-Jun are accomplices with each other during VK3/
VC-induced apoptosis in leukemia cells. Furthermore,
JNK interacts with p53 in response to stress [35]. We
conclude that induction of NF-B, JNK/c-Jun, and p53
by VK3 and VC might be particularly suitable for the
treatment of leukemia [31,36].
During the last decade, VC and VK3 administered in a
ratio 100:1 respectively, exhibit synergistic anti-tumor
activity by a cell death process denominated autoschizis.
This cell death is a type of necrosis characterized by
exaggerated membrane damage and progressive loss of
cytoplasm through a series of self-excisions [37].
Because cell death is a pure morphological phenomenon
[6], we used acridine orange/ethidium bromide (AO/EB)
staining as one of the most reliable and unbiased
method to identify live, (early and late) apoptotic and
necrotic cell [22] compared to other standard methods
[38]. Therefore, we first consistently found that (10 μM)
VK3 and (10 mM) VC induced (early and late) apoptosis
judged against N,N,N′,N′-tetrakis-(2-Pyridylmethyl)ethy-
lenediamine (5 μM, TPEN) reagent, which induces 100%
nuclei apoptotic morphology in a caspase-3 and p53-
dependent fashion in Jurkat cell line (control, data not
shown). We found a ratio 100:1 VC: VK3 induced no
cell death and mitochondrial damage in Jurkat cells.
However, a significant percentage of (late) apoptotic
morphology and depolarized mitochondria in cells were
provoked by a ratio 1000:1 (VC: VK3) compared to cells
treated with VC and VK3 alone. In agreement with
others data, it is found that a ratio 100:1 VC: VK3
induced cell death and mitochondrial damage in K562.
Strikingly, Jurkat and K562 cells showed classical apop-
tosis and necrosis [6] rather than autoschizis morphol-
ogy [37]. Furthermore, it was found that (1000:1; 100:1)
VC/VK3 activates NF-B, p53, c-Jun and caspase-3,
typical of apoptosis. In agreement with Sakagami et al
[39] and Ogawa et al. [40], altogether our data suggest
that VK3 and VC induce apoptosis in leukemia cells by
oxidative stress [41]. In contrast to other reports
[15,42-44], our data suggest that autoschizis might not
be operative, at least under the present experimental
conditions, in Jurkat and K562 cells. Taken together
these results imply that VC- and VK3-induced autoschi-
zis is a cell-specific rather than universal cell death pro-
cess. Altogether our data suggest that a (1000:1; 100:1)
VC: VK3 dose should be an intravenously therapeutic
dose in the treatment of lymphoblastic and myelogenous
leukemia.
Conclusion
We provide evidence that VK3 and VC alone or in com-
bination induces apoptosis in leukemia cells by a
sequential cascade of molecular events involving the
production of ROS, simultaneous activation of NF-B/
p53/c-Jun transcription factors, mitochondrial depolari-
zation and caspase-3 activation pathway. These data
Table 3 NF-B, p53, c-Jun and caspase-3 molecules are
involved in vitamin K3 (VK3)- and vitamin C (VC)-induced






Untreated < 1 ± 0 > 99 ± 0
VK3 (10 μM) 35 ± 3 63 ± 2
VC (10 mM) 26 ± 2 73 ± 3
VK3 (10 μM) + VC (10 mM) 58 ± 3 63 ± 3
PDTC (10 nM) < 1 ± 0 > 99 ± 0
PDTC (10 nM) + VK3 (10 μM) 3 ± 1
a 97 ± 1
a
PDTC (10 nM) + VC (10 mM) 8 ± 2
b 90 ± 2
b
PDTC (10 nM) + VK3 (10 μM) + VC
(10 mM)
13 ± 2
c 80 ± 3
c
PFT (50 nM) < 1 ± 0 > 99 ± 0
PFT (50 nM) + VK3 (10 μM) 4 ± 1
a 98 ± 1
a
PFT (50 nM) + VC (10 mM) 3 ± 1
b 95 ± 2
b
PFT (50 nM) + VK3 (10 μM) + VC
(10 mM)
6±2
c 92 ± 3
c
SP600125 (1 μM) 2 ± 1 97 ± 2
SP600125 (1 μM) + VK3 (10 μM) 6 ± 2
a 90 ± 3
a
SP600125 (1 μM) + VC (10 mM) 8 ± 2
b 89 ± 3
b
SP600125 (1 μM) + VK3 (10 μM) + VC
(10 mM)
20 ± 2
c 80 ± 3
c
NSCI (10 μM ) <1±0 >9 9±0
NSCI (10 μM) + VK3 (10 μM) 3 ± 1
a 95 ± 2
a
NSCI (10 μM) + VC (10 mM) 8 ± 1
b 95 ± 3
b
NSCI (10 μM) + VK3 (10 μM) + VC
(10 mM)
8±1
c 95 ± 3
c
Jurkat cells (1 × 10
6 cell/mL) were left untreated or treated with specific NF-
B, p53, c-Jun and caspase-3 inhibitors such as ammonium
pyrrolidinedithiocarbamate (PDTC, 10 nM), pifithrin-a (PFT, 50 nM), SP600125
(1 μM) and NSCI (10 μM) alone or in presence of VK3 (10 μM), VC (10 mM), VC
(10 mM): VK3 (10 μM) at 37 °C for 24 h. After this time, nuclear morphologic
and mitochondrial membrane potential changes as a result of NF-B, p53, c-
Jun, and caspase-3 activation were evaluated using acridine orange/ethidium
bromide (AO/EB) and DiOC6(3) staining, as described in Materials and Methods.
High polarized and low-polarized mitochondria (green fluorescent DiOC6(3)
high/low positive cells) and positive apoptotic nuclei percentage is expressed
as mean of percentage (%) ± S.D. from three independent experiments. A
one-way ANOVA analysis was performed, p < 0.0001.
aSignificantly different
from VK3 by Bonferroni post-hoc analysis for DiOC6(3) and AO/EB.
bSignificantly different from VC by Bonferroni post-hoc analysis for DiOC6(3)
and AO/EB.
cSignificantly different from VK3-VC by Bonferroni post-hoc
analysis for DiOC6(3) and AO/EB.
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Page 6 of 11Figure 3 Vitamin K3 (VK3) alone induces simultaneous activation of the transcription factor NF-B, p53, c-Jun and protease caspase-3
in Jurkat cells. Jurkat cells were left untreated (A, C, E, G) or exposed to (10 μM) VK3 (B, D, F, H), at 37 °C for 24 h. After this time of incubation,
cells were stained with anti-NF-B-p65 (A, B), anti-p53 (C, D), anti-c-Jun (E, F) and anti-caspase-3 (G, H) antibodies according to procedure
described in Materials and Methods. Notice that NF-B, p53, c-Jun and caspase-3 (CASP-3) positive-nuclei (dark brown color) reflect their nuclear
translocation/activation and appear to correlate with the apoptotic nuclear morphology, i.e. condensed/fragmented nuclei compared with
untreated cells (A, C, E, G) or cytoplasmic activation (brown color). Magnification 660x (A-H). Inset Magnification (B, 2000x; D:1100x).
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Page 7 of 11Figure 4 Vitamin C (VC) alone or in combination with vitamin K3 (VK3: VC) induce simultaneous activation of the transcription factor
NF-B, p53, c-Jun and protease caspase-3 in Jurkat cells. Jurkat cells were exposed to (10 mM) VC (A, C, E, G) and (10 μM) VK3 plus (10
mM) VC (B, D, F, H) for 24 h. After this time of incubation, cells were stained with anti-NF-B-p65 (A, B), anti-p53 (C, D), anti-c-Jun (E, F) and anti-
caspase-3 (G, H) antibodies according to procedure described in Materials and Methods. Notice that NF-B, p53, c-Jun and caspase-3 (CASP-3)
positive-nuclei (dark brown color) reflect their nuclear translocation/activation and appear to correlate with the apoptotic nuclear morphology,i .
e. condensed/fragmented nuclei compared with untreated cells (Figure 3 A, C, E, G) or cytoplasmic activation (brown color). Magnification 660x
(A-H). Inset Magnification (A: 2000x).
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Page 8 of 11confirm our hypothesis that VK3 and VC kill leukemia
cells by oxidative stress mechanism. Most importantly,
VK3 and VC are harmless to lymphocytes, at least
under the present in vitro conditions. Taken together
our results support the notion that oxidative stress may
play an important role in the killing of leukemia cells.
Methods
Materials
Reagents were purchased from Sigma-Aldrich (St. Louis,
MO, USA) if not otherwise specified and were of analy-
tical grade or better. 3,3’-dihexyloxacarbocyanine iodide
(DiOc6(3), cat # D-273) was obtained from Invitrogen
Molecular Probes (Eugene, OR, USA). Ammonium pyr-
rolidinedithiocarbamate (PDTC, cat. # 548000) and 1,9-
pyrazoloanthrone (SP600125, cat # 420119) were
acquired from Calbiochem (San Diego, CA, USA).
Isolation of lymphocytes
Peripheral blood lymphocytes were obtained from
healthy adult (30-40 years old) males’ venous blood by
gradient centrifugation (lymphocyte separation medium,
density: 1.007 G/M; Bio-Whittaker Inc., Walkersville,
MD, USA) and cultured as described elsewhere [45].
Cancer cell culture
Jurkat clone E6-1 (ATCC
® Catalog No. TIB-152™)a n d
K562 (ATCC
® Catalog No. CCL-243™)w e r ec u l t u r e d
according to supplier’s indications. Cells at 1 × 10
6 cells/
mL (passage 5-10) were exposed to Vitamin K3 (VK3)
and/or Vitamin C (VC) and other products of interest.
Experiments with leukemia cell line and lymphocyte cells
Morphological assessment of cell death by fluorescence
microscopy using acridine orange/ethidium bromide
(AO/EB) double staining
The cell suspension (1 mL, final volume) was exposed to
increasing vitamin K3 (1, 5, 10, 20, 35, 50 μM), vitamin C
( a s c o r b i ca c i da tp H7 ;0 . 1 ,0 . 5 ,1 ,5 ,1 0 ,2 0m M )o r
10 mM VC: 10 μM VK3 concentrations freshly prepared
in RPMI-1640 medium in the absence or presence of dif-
ferent products of interest for 24 h at 37 °C. The cells
were then used for fluorescent microscopy analysis as
detailed elsewhere [45].
Evaluation of intracellular reactive oxygen species
Assessment of superoxide anion radical generation
Superoxide anion radicals were evaluated as described
elsewhere [46]. Formazan was quantified under a light
microscope (Zeiss Axiostart 50).
Assessment of Hydrogen peroxide
H2O2 was evaluated as described elsewhere [45],
except that 2’,7’-dichlorofluorescein diacetate (DCFH2-
DA) was used instead of dihydrorhodamine 123
(DHR-123). Green fluorescent cells (reflecting H2O2
production) were quantified under a fluorescence
microscope.
Qualitative analysis of mitochondrial membrane potential
(Δψm)
The cancer cell lines were treated as described above
and incubated with cationic lipophilic DiOC6(3) (1 μM,
final concentration) to evaluate Δψm as detailed else-
where [45]. Green fluorescent cells (reflecting high-
polarized and low-polarized mitochondria) were quanti-
fied under a fluorescence microscope.
Immunocytochemistry detection of NF-B, p53 and c-Jun
transcription factor and caspase-3 protein
The Santa Cruz Biotechnology supplier protocol (goat
ABC staining System: cat # sc-2023) was followed for
the immunocytochemistry using primary goat polyclonal
antibodies NF-B p65 (C-20)-G (cat#sc-372-G), p53
(FL-393) (cat #sc-6243-G), p-(Ser 73)-c-Jun (cat #sc-
7981) and caspase-3 (cat #sc-22171). Immunocytochem-
istry procedure was performed as detailed elsewhere
[45]. DAB
+ cells were quantified under a light
microscope.
Photomicrography
The light microscopy and fluorescent photomicrographs
shown in figures and supplemental ones were taken
using a Zeiss (Axiostart 50) microscope equipped with a
Canon PowerShot G5 digital camera.
Statistical Analysis
The aforementioned parameters were quantified by
counting a minimum of 500 total cells blind to experi-
mental setting and viewer. The experiments were per-
formed in 3 independent settings. Data are means ± S.D.
of three independent experiments. One-way ANOVA
analyses with Bonferroni or Games-Howell post-hoc
comparison were calculated with SPSS 18 software. A
p-value of < 0.05 and < 0.001 was considered significant.
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